Approval · Notice of Compliance 9959 · 2008
METOJECT: Notice of Compliance 9959
Issued December 22, 2008
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9959
- Date
- December 22, 2008
- Company
- Medexus Inc
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Admin
- Reason
- Addition of new strengths
- Therapeutic class
- Antimetabolite / antirheumatic
- Canadian reference product
- METHOTREXATE INJECTION USP (Mayne Pharma (Canada) Inc.)
Products in this notice
Medicinal ingredients
- METHOTREXATE SODIUM 7.5 MG per 0.75ML
- METHOTREXATE SODIUM 10 MG per ML
- METHOTREXATE SODIUM 15 MG per 1.5ML
- METHOTREXATE SODIUM 25 MG per 2.5ML